Titan Pharmaceuticals, Inc. (TTNP) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 | Q1'21 | Q4'20 | Q3'20 |
|---|
| Sales/Revenue | 0 | 0 | 10K | 0 | 0 | 0 | 81K | 4K | 1K | 98K | 51K | 4K | 150K | 192K | 135K | 264K | 445K | 682K | 1.06M | 1.12M |
| Revenue Growth % | - | - | -87.65% | -100% | -100% | -100% | 58.82% | 0% | -99.33% | -48.96% | -62.22% | -98.48% | -66.29% | -71.85% | -87.23% | -76.43% | -66.42% | -48.95% | -13.15% | 18.27% |
| Cost of Goods Sold | 0 | 0 | 0 | 0 | 0 | 0 | 3K | 27K | 442K | 43K | 0 | 932K | 51K | 52K | 53K | 1.19M | 89K | 110K | 2.04M | 683K |
| COGS % of Revenue | - | - | - | - | - | - | 3.7% | 675% | 44200% | 43.88% | - | 23300% | 34% | 27.08% | 39.26% | 451.89% | 20% | 16.13% | 193.47% | 60.98% |
| Gross Profit | 0 | 0 | 5K | 0 | 0 | 0 | 78K | -23K | -441K | 55K | 51K | -928K | 99K | 140K | 82K | -929K | 356K | 572K | -988K | 437K |
| Gross Margin % | - | - | 50% | - | - | - | 96.3% | -575% | -44100% | 56.12% | 100% | -23200% | 66% | 72.92% | 60.74% | -351.89% | 80% | 83.87% | -93.47% | 39.02% |
| Gross Profit Growth % | - | - | -93.59% | 100% | 100% | -100% | 52.94% | 97.52% | -545.45% | -60.71% | -37.8% | 0.11% | -72.19% | -75.52% | 108.3% | -312.59% | -67.55% | -50.9% | -248.13% | -42.42% |
| Operating Expenses | 657K | 534K | 666K | 754K | 2.07M | 1.06M | 1.93M | 2.06M | 1.59M | 1.7M | 2.66M | 2.65M | 2.59M | 2.73M | 2.62M | 2.17M | 2.68M | 3.2M | -4.27M | 5.11M |
| OpEx % of Revenue | - | - | 6660% | - | - | - | 2380.25% | 51525% | 158900% | 1731.63% | 5219.61% | 66175% | 1728% | 1422.4% | 1943.7% | 822.73% | 602.47% | 469.79% | -403.6% | 456.34% |
| Selling, General & Admin | 657K | 534K | 666K | 754K | 2.07M | 1.06M | 1.44M | 1.64M | 1.23M | 1.23M | 1.29M | 1.81M | 1.62M | 1.32M | 1.65M | 979K | 1.03M | 1.33M | -4.34M | 3.55M |
| SG&A % of Revenue | - | - | 6660% | - | - | - | 1779.01% | 41025% | 122900% | 1259.18% | 2527.45% | 45150% | 1078.67% | 688.54% | 1220.74% | 370.83% | 232.58% | 194.57% | -410.22% | 316.88% |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 | 487K | 424K | 442K | 561K | 1.44M | 932K | 974K | 1.41M | 976K | 1.19M | 1.65M | 1.88M | 70K | 1.56M |
| R&D % of Revenue | - | - | - | - | - | - | 601.23% | 10600% | 44200% | 572.45% | 2829.41% | 23300% | 649.33% | 733.85% | 722.96% | 451.89% | 369.89% | 275.22% | 6.62% | 139.46% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 2K | 0 | 2K | -5K | -98K | -70K | -16K | -25K | -1K | -54K | -7K | -16K | -8K | 1000K | -12K |
| Operating Income | -657K | -534K | -666K | -754K | -2.07M | -1.06M | -1.93M | -2.06M | -1.59M | -1.7M | -2.61M | -2.64M | -2.44M | -2.54M | -2.49M | -1.91M | -2.33M | -2.63M | 5.93M | -4.67M |
| Operating Margin % | - | - | -6660% | - | - | - | -2383.95% | -51525% | -158800% | -1731.63% | -5119.61% | -66075% | -1628% | -1322.4% | -1843.7% | -722.73% | -522.47% | -385.92% | 561.21% | -417.32% |
| Operating Income Growth % | 68.32% | 49.76% | 65.51% | 63.42% | -30.6% | 37.36% | 26.04% | 22.02% | 34.97% | 33.16% | -4.9% | -38.52% | -5.03% | 3.53% | -141.96% | 59.18% | 46.97% | 37.72% | 256.35% | -20.37% |
| EBITDA | -657K | -534K | -666K | -754K | -2.07M | -1.06M | -1.93M | -2.03M | -1.55M | -1.65M | -2.57M | -2.6M | -2.39M | -2.49M | -2.44M | -1.85M | -2.27M | -2.58M | 6M | -4.58M |
| EBITDA Margin % | - | - | -6660% | - | - | - | -2380.25% | -50850% | -154900% | -1687.76% | -5031.37% | -64875% | -1594% | -1295.31% | -1804.44% | -701.52% | -509.66% | -377.86% | 567.36% | -408.48% |
| EBITDA Growth % | 68.28% | 49.67% | 65.46% | 62.93% | -33.7% | 35.85% | 24.86% | 21.62% | 35.22% | 33.49% | -5.34% | -40.12% | -5.42% | 3.49% | -140.62% | 59.52% | 47.48% | 38.11% | 260.52% | -19.76% |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 | 0 | 3K | 2K | 3K | 27K | 39K | 43K | 45K | 48K | 51K | 52K | 53K | 56K | 57K | 55K | 65K | 99K |
| EBIT | -657K | -534K | -666K | -754K | -2.07M | -1.06M | -1.93M | -2.06M | -1.59M | -1.7M | -2.61M | -2.64M | -2.44M | -2.54M | -3.12M | -1.91M | -2.33M | -2.64M | 7.8M | -4.69M |
| Net Interest Income | 0 | 0 | -1K | 0 | 0 | 1K | -13K | -11K | 7K | 22K | 27K | 21K | 5K | -1K | 3K | 0 | 0 | -1K | -51K | -246K |
| Interest Income | 0 | 0 | -1K | 0 | 0 | 1K | 0 | 0 | 7K | 22K | 27K | 21K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 33K | 11K | 0 | 0 | 0 | 0 | 5K | 1K | 3K | 0 | 0 | 1K | 51K | 246K |
| Other Income/Expense | -32K | -29K | -124K | -9K | -19K | 3K | -39K | 1.72M | 2K | 22K | 45K | 5K | -20K | -1K | -51K | -7K | 645K | -9K | 1.82M | 3.45M |
| Pretax Income | -689K | -563K | -790K | -763K | -2.09M | -1.06M | -1.97M | -338K | -1.59M | -1.68M | -2.57M | -2.64M | -2.46M | -2.54M | -2.54M | -1.92M | -1.68M | -2.64M | 7.75M | -1.22M |
| Pretax Margin % | - | - | -7900% | - | - | - | -2432.1% | -8450% | -158600% | -1709.18% | -5031.37% | -65950% | -1641.33% | -1322.92% | -1881.48% | -725.38% | -377.53% | -387.24% | 733.21% | -109.02% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 234K |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | -19.16% |
| Net Income | -689K | -563K | -790K | -763K | -2.09M | -1.06M | -1.97M | -338K | -1.59M | -1.65M | -2.57M | -2.64M | -2.48M | -2.54M | -2.54M | -1.92M | -1.68M | -2.64M | -3.08M | -4.93M |
| Net Margin % | - | - | -7900% | - | - | - | -2432.1% | -8450% | -158600% | -1686.73% | -5031.37% | -65950% | -1654.67% | -1323.44% | -1881.48% | -725.38% | -377.53% | -387.24% | -291.86% | -440.36% |
| Net Income Growth % | 67.08% | 46.89% | 59.9% | -125.74% | -31.97% | 35.87% | 23.23% | 87.19% | 36.1% | 34.95% | -1.02% | -37.75% | -47.74% | 3.79% | 17.67% | 61.17% | 63.8% | 52.7% | 21.72% | -75.95% |
| Net Income (Continuing) | -689K | -563K | -790K | -763K | -2.09M | -1.06M | -1.97M | -338K | -1.59M | -1.68M | -2.57M | -2.64M | -2.46M | -2.54M | -2.54M | -1.92M | -1.68M | -2.64M | 7.75M | -1.46M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1000K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.65 | -0.62 | -0.88 | -0.83 | -2.29 | -1.24 | -2.52 | -0.45 | -2.11 | -2.20 | -3.61 | -3.61 | -1.24 | -1.27 | -1.27 | -0.96 | -0.84 | -1.32 | -1.54 | -1.51 |
| EPS Growth % | 71.62% | 50% | 65.08% | -84.44% | -8.53% | 43.64% | 30.19% | 87.53% | -70.16% | -73.23% | -184.25% | -276.04% | -47.62% | 3.79% | 17.53% | 36.42% | 42.86% | 34.98% | -7.69% | 72.14% |
| EPS (Basic) | -0.65 | -0.62 | -0.88 | -0.83 | -2.29 | -1.24 | -2.52 | -0.45 | -2.11 | -2.20 | -3.61 | -3.61 | -1.24 | -1.27 | -1.27 | -0.96 | -0.84 | -1.32 | -1.54 | -1.51 |
| Diluted Shares Outstanding | 1.06M | 914K | 899K | 914K | 914K | 853K | 781.5K | 750.8K | 750.8K | 750.8K | 711.25K | 731.45K | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 3.26M |
| Basic Shares Outstanding | 1.06M | 914K | 899K | 914K | 914K | 853K | 781.5K | 750.8K | 750.8K | 750.8K | 711.25K | 731.45K | 2M | 2M | 2M | 2M | 2M | 2M | 2M | 3.26M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |